CURIA ITALY SRL

Overview

CURIA ITALY SRL is an active pharmaceutical ingredient (API) supplier with 40 active FDA Type II Drug Master Files, covering 1-LZD; 31/AC HCL; 5-THIAZOLE WING; A-84538.0 (RITONAVIR); ARGATROBAN; ARGATROBAN MONOHYDRATE.

Core services & business areas

Active pharmaceutical ingredients supplied

Substances CURIA ITALY SRL is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

API / Drug Master Files

CURIA ITALY SRL holds 40 active (40 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ARGATROBAN MONOHYDRATEActive2024-08-30
• MONOMETHYL FUMARATEActive2023-06-30
• CYCLOSPORINE 350507Active2021-10-14
• OXANDROLONEActive2020-03-17
• DESOGESTRELActive2020-01-27
• ROCURONIUM BROMIDEActive2019-12-06
• AZTREONAM ALFA FORMActive2019-04-09
• AZTREONAM BETA FORMActive2019-04-05
• MINOCYCLINE HYDROCHLORIDE (DIHYDRATE) MICRONIZEDActive2018-11-28
• PIMECROLIMUSActive2017-12-14
• SODIUM MYCOPHENOLATEActive2010-06-04
• ERGOTAMINE TARTRATE USP/EPActive2009-07-06
• DIHYDROLYSERGIC ACID (INTERMEDIATE)Active2009-05-01
• DIHYDROERGOTAMINE MESYLATE USP/EPActive2009-01-13
• SIROLIMUSActive2007-11-13

Showing 15 of 40 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CURIA ITALY SRL in our records. PharmaTek screens the full directory against live FDA enforcement data.